Subscribe   RSS Contact Us

Kamp Commentary: Pricing Issues Take Center Stage in D.C.

May 23, 2017 — By Coalition for Healthcare Communication Executive Director John Kamp Participants at last week’s Coalition for Healthcare ... read more

Califf Calls for Off-label Promotion Code of Ethics

May 18, 2017 – At this week’s information-packed Coalition for Healthcare Communication’s Rising Leaders Conference, keynote speaker and former FDA ... read more

The Marketing Implications of Tax Reform

By John Kamp, Coalition for Healthcare Communication Executive Director May 11, 2017 – Although no one seems to like the ... read more

Gottlieb Vote Headed to Full Senate

May 1, 2017 – Having cleared the Senate Committee on Health, Education, Labor and Pensions (HELP) with a 14-9 vote ... read more

What Medical Marketers Can Expect from President Trump, Republican-led Congress

April 24, 2017 – There is no doubt that the Trump administration is likely to change health policy, but the ... read more

Kamp: Three Ways Congress Could Suppress DTC or All Medical Marketing

Coalition Commentary by Executive Director John Kamp April 17, 2017 — Agencies, media and clients all need to watch closely ... read more

States Make Moves to Ease, Restrict Medical Communications

March 31, 2017 – With Congress in a seemingly permanent state of gridlock, individual states are taking actions that may ... read more

Previous Next

Califf Calls for Off-label Promotion Code of Ethics

May 18, 2017 – At this week’s information-packed Coalition for Healthcare Communication’s Rising Leaders Conference, keynote speaker and former FDA Commissioner Robert Califf said that “healthcare marketers need to create a code of ethics to promote drugs for truthful and non-misleading uses outside their FDA-approved labels, commonly referred to as off-label promotion,” according to coverage of the meeting in MM&M.

“Given the deregulated state [of off-label promotion], you need to come up with a code of ethics,” Califf advised attendees at the Monday session, MM&M reported. “Your efforts should be truthful and non-misleading,” Califf added. “Truthful you get, non-misleading is really hard. It’s like a bad marriage; it’s not what you say. It’s what you didn’t say. The misleading part is where you need to focus.”

To view the full article, go to: http://www.mmm-online.com/legalregulatory/fda-off-label-promotion-califf-marketing-advertising-pharma/article/661852/?DCMP=EMC-MMM_Newsbrief_20170516&cpn=mmmcpn&spMailingID=17241742&spUserID=NzAzNDA1MTY4ODQS1&spJobID=1021335603&spReportId=MTAyMTMzNTYwMwS2